Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.3 with new dates (2026-03-03, 2026-03-05, 2026-03) and the previous revision v3.4.2 removed.
    Difference
    0.2%
    Check dated 2026-03-12T00:28:17.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag appears and the prior government funding lapse notice is removed; the study details and page content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:17:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:36.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Glossary display option added and metadata updated to Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. The previous metadata items were renamed/removed to Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:31:52.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A minor version update from v3.3.3 to v3.3.4 was applied; no visible changes to core page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:39:45.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section identifying Texas (Houston, MD Anderson Cancer Center) as a study site; removed the old Texas Locations entry and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:02.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.